Krsnaa Diagnostics Receives BSE Approval for 16.21 Lakh Promoter Warrants
Krsnaa Diagnostics Ltd 路 Others (Uncategorized) 路 10 Oct 2026, 12:49 am
Krsnaa Diagnostics Receives BSE Approval for 16.21 Lakh Promoter Warrants Krsnaa Diagnostics received a corrected in-principle approval letter from BSE Ltd on 9th Oct'26 for the preferential issue of 16,21,000 warrants convertible into an equivalent number of equity shares (face value Rs. 5 each) to its Promoter and Promoter Group. The issue price is fixed at Rs. 566 per warrant, totaling approximately Rs. 91.75 Cr. The updated approval rectifies factual errors from an earlier letter. The allotment remains subject to standard statutory compliances and subsequent post-issue listing formalities within stipulated exchange timelines.
Original exchange filing (PDF)
More announcements from Krsnaa Diagnostics Ltd
- Earnings Call Transcript for quarter and half year ended September 30, 2026 路 08 Nov 2026
- Intimation of Change in Corporate office of Registrar and Sahre Trasnfer Agent of the Company w.e.f. 1st December 2026. 路 04 Nov 2026
- Audio recording of conference call for the quarter and half year ended September 30, 2026 路 04 Nov 2026
- Submission of Certificate obtained from Statutory Auditors in terms of Regulation 169(5) of the SEBI ICDR Regulations, 2018 路 03 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Krsnaa Diagnostics secures 15 year Cash based PPP project from Municipal corporation of Delhi for Advanced CT Scan and .... 路 03 Nov 2026
- Investor Presentation for the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026 路 03 Nov 2026
- Press Release - Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026 路 03 Nov 2026
- Financial Results for Quarter and Half Year ended September 30, 2026 路 02 Nov 2026
